Product Information
DUPIXENT 300 MG/2 ML SYRINGE is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $1010.3009 per ML under NDC 00024591401. Its NADAC has been published 367 times since Jun 19, 2019.
Strength
300 mg/2mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024591401
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
DUPILUMABApproval Type
Biologic (BLA)
FDA Application
BLA761055On Market Since
3/28/2017
Pharmacological Classes
Price Statistics
The NADAC for DUPIXENT 300 MG/2 ML SYRINGE has been published 367 times since Jun 19, 2019, and over the history we have for it it has risen 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1010.3009 per ML |
|---|---|
| All-time high | $1010.5190 (Jun 10, 2026) |
| All-time low | $729.5237 (Jun 19, 2019) |
| 52-week high | $1010.5190 |
| 52-week low | $961.8646 |
| Median price | $818.2954 |
| Average price | $848.6912 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 367 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DUPIXENT 300 MG/2 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for DUPIXENT 300 MG/2 ML SYRINGE, manufactured by Sanofi-Aventis U.S. LLC, is $1010.3009 per ML (NDC 00024591401), effective Jun 24, 2026.
How has the price of DUPIXENT 300 MG/2 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for DUPIXENT 300 MG/2 ML SYRINGE has risen 38.5%. It has been tracked across 367 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for DUPIXENT 300 MG/2 ML SYRINGE?
Since Jun 19, 2019, the NADAC for DUPIXENT 300 MG/2 ML SYRINGE has ranged from a low of $729.5237 (Jun 19, 2019) to a high of $1010.5190 (Jun 10, 2026), with a median of $818.2954 per ML.
Are there cheaper alternatives to DUPIXENT 300 MG/2 ML SYRINGE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, DUPIXENT 300 MG/2 ML PEN, is $1009.2936 per ML — about 0% below DUPIXENT 300 MG/2 ML SYRINGE.
Who manufactures DUPIXENT 300 MG/2 ML SYRINGE?
DUPIXENT 300 MG/2 ML SYRINGE (NDC 00024591401) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification